Items where authors include "Rugo, H.S."

Article

Rugo, H.S. orcid.org/0000-0001-6710-4814, Van Poznak, C.H. orcid.org/0000-0001-5523-6908, Neven, P. orcid.org/0000-0002-1434-9460 et al. (12 more authors) (2024) Radium-223 in women with hormone receptor-positive bone-metastatic breast cancer receiving endocrine therapy: pooled analysis of two international, phase 2, randomized, double-blind, placebo-controlled trials. Breast Cancer Research and Treatment, 204 (2). pp. 249-259. ISSN 0167-6806

Tripathy, D., Tolaney, S.M., Seidman, A.D. et al. (73 more authors) (2022) Treatment With Etirinotecan Pegol for Patients With Metastatic Breast Cancer and Brain Metastases: Final Results From the Phase 3 ATTAIN Randomized Clinical Trial. JAMA Oncology, 8 (7). pp. 1047-1052. ISSN 2374-2437

Kittaneh, M., Badve, S., Caldera, H. et al. (12 more authors) (2020) Case-based review and olinical guidance on the use of genomic assays for early-stage breast cancer: Breast Cancer Therapy Expert Group (BCTEG). Clinical Breast Cancer, 20 (3). pp. 183-193. ISSN 1526-8209

Proceedings Paper

Goetz, M.P., Wander, S.A., Bachelot, T. et al. (17 more authors) (2024) Open-label, randomized, multicenter, phase 3, ELAINE 3 study of the efficacy and safety of lasofoxifene plus abemaciclib for treating ER+/HER2-, locally advanced or metastatic breast cancer with an ESR1 mutation. In: Journal of Clinical Oncology. 2024 ASCO Annual Meeting, 31 May - 04 Jun 2024, Chicago, USA. American Society of Clinical Oncology .